ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Yazar: | |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
"Paediatrician" Publishers LLC
2008-08-01
|
Seri Bilgileri: | Вопросы современной педиатрии |
Online Erişim: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Search Result 1
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Baskı/Yayın Bilgisi 2008-01-01
Tam Metin Erişim
Makale